Thomas Czajkowski, MD
Family Medicine · Allentown, PANPI 1134136385
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 667 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 667 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$2K
- Amgen$2K
- Novo Nordisk$1K
- Lilly USA, LLC$915
- Boehringer Ingelheim$761
- plus $4K from 32 others
What the payments were for
- Food & beverage$12,11896%
- Education$4994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 121 | $2,200 |
| AstraZeneca | 81 | $2,005 |
| Amgen(2 entities) | 104 | $1,623 |
| Novo Nordisk | 64 | $1,039 |
| Lilly USA, LLC | 58 | $915 |
| Boehringer Ingelheim | 30 | $761 |
| Astellas Pharma US Inc | 22 | $713 |
| Pfizer | 29 | $546 |
| Merck | 22 | $360 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $295 |
| Amarin Pharma, Inc. | 9 | $204 |
| Johnson & Johnson | 12 | $183 |
| GSK | 7 | $141 |
| Abbott | 6 | $117 |
| Exact Sciences | 5 | $114 |
| Bayer | 1 | $113 |
| Axsome Therapeutics, Inc. | 6 | $111 |
| Esperion Therapeutics, Inc. | 5 | $108 |
| Ardelyx, Inc. | 5 | $99 |
| Sanofi-aventis U.S. LLC | 7 | $99 |
| Almatica Pharma LLC | 5 | $97 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $94 |
| Novartis | 5 | $92 |
| Phathom Pharmaceuticals, Inc. | 6 | $92 |
| E.r. Squibb & Sons, L.L.C. | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $62 |
| Azurity Pharmaceuticals, Inc. | 3 | $57 |
| Gilead | 4 | $56 |
| Phadia US Inc. | 2 | $52 |
| Biohaven Pharmaceuticals, Inc. | 3 | $41 |
| Eisai Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Therapeuticsmd, Inc. | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Vistapharm, Inc. | 1 | $14 |
| Mannkind Corporation | 1 | $11 |
| Scilex Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,617 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 135 | $104,986 |
| TradjentaLinagliptin | 46 | $49,038 |
| FarxigaDapagliflozin Propanediol | 38 | $45,049 |
| JanuviaSitagliptin Phosphate | 30 | $41,711 |
| TrulicityDulaglutide | 31 | $40,078 |
| XareltoRivaroxaban | 38 | $28,791 |
| JardianceEmpagliflozin | 22 | $21,508 |
| WegovySemaglutide | 12 | $15,097 |
| MounjaroTirzepatide | 11 | $11,137 |
| JanumetSitagliptin Phos/Metformin Hcl | 24 | $10,423 |
| EntrestoSacubitril/Valsartan | 17 | $8,582 |
| Serevent DiskusSalmeterol Xinafoate | 12 | $4,328 |
| Icosapent Ethyl | 19 | $4,093 |
| Atorvastatin Calcium | 232 | $2,917 |
| PaxlovidNirmatrelvir/Ritonavir | 20 | $2,859 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $546 | $107,845155 claims |
| Boehringer IngelheimTradjenta, Jardiance | $761 | $70,54668 claims |
| MerckJanuvia, Janumet | $360 | $52,13454 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $915 | $51,21542 claims |
| AstraZenecaFarxiga | $2,005 | $45,04938 claims |
| Johnson & JohnsonXarelto | $183 | $28,79138 claims |
| Novo NordiskWegovy | $1,039 | $15,09712 claims |
| NovartisEntresto | $92 | $8,58217 claims |
| AbbVieSynthroid | $2,200 | $1,42820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Allentown
- Joseph BognetAllentown$39K
- Mary StockAllentown$26K
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.